InChI=1S/C20H35NO/c1- 2- 3- 4- 5- 6- 7- 8- 9- 10- 11- 12- 13- 14- 15- 16- 17- 18- 19- 20(21) 22/h6- 7,9- 10,12- 13H,2- 5,8,11,14- 19H2,1H3,(H2,21,22) /b7- 6- ,10- 9- ,13- 12- |
FEEKQVCOKHTLSP-QNEBEIHSSA-N |
C(CCC(N)=O)CCC/C=C\C/C=C\C/C=C\CCCCC |
|
(8Z,11Z,14Z)-icosa-8,11,14-trienamide
|
(8Z,11Z,14Z)-eicosatrienamide
|
UniProt
|
(Z,Z,Z)-icosa-8,11,14-trienamide
|
ChEBI
|
all-cis-icosa-8,11,14-eicosatrienamide
|
ChEBI
|
all-cis-icosa-8,11,14-icosatrienamide
|
ChEBI
|
Boger DL, Fecik RA, Patterson JE, Miyauchi H, Patricelli MP, Cravatt BF (2000) Fatty acid amide hydrolase substrate specificity. Bioorganic & medicinal chemistry letters 10, 2613-2616 (Source: SUBMITTER) [PubMed:11128635] [show Abstract] Fatty acid amide hydrolase (FAAH), also referred to as oleamide hydrolase and anandamide amidohydrolase, is a serine hydrolase responsible for the degradation of endogenous oleamide and anandamide, fatty acid amides that function as chemical messengers. FAAH hydrolyzes a range of fatty acid amides, and the present study examines the relative rates of hydrolysis of a variety of natural and unnatural fatty acid primary amide substrates using pure recombinant rat FAAH. |
|